Roche 

€34.28
1341
-€0.61-1.75% Friday 06:13

統計

當日最高
34.28
當日最低
34.28
52週最高
-
52週最低
-
成交量
0
平均成交量
-
市值
231.5B
市盈率
20.84
股息收益率
3.59%
股息
1.23

即將到來

股息

3.59%股息收益率
10年增長
1.98%
5年增長率
4.66%
3年增長率
3.4%
1年增長率
5.47%

收益

23Jul預期
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0
3.96
7.91
11.87
預期每股收益
10.4166895
實際每股收益
11.378829

人們還關注

此列表基於在 Stock Events 上關注 RHO6.F 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
Show more...
首席執行官
Dr. Severin Schwan Ph.D.
員工
103605
國家
US
ISIN
US7711951043
WKN
000891106

上市公司